title: Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.
abstract: Primitive subsets of leukemic cells isolated by using fluorescence-activated cell sorting from patients with newly diagnosed Ph(+)/BCR-ABL(+) chronic myeloid leukemia display an abnormal ability to proliferate in vitro in the absence of added growth factors. We now show from analyses of growth-factor gene expression, protein production, and antibody inhibition studies that this deregulated growth can be explained, at least in part, by a novel differentiation-controlled autocrine mechanism. This mechanism involves the consistent and selective activation of IL-3 and granulocyte colony-stimulating factor (G-CSF) production and a stimulation of STAT5 phosphorylation in CD34(+) leukemic cells. When these cells differentiate into CD34(-) cells in vivo, IL-3 and G-CSF production declines, and the cells concomitantly lose their capacity for autonomous growth in vitro despite their continued expression of BCR-ABL. Based on previous studies of normal cells, excessive exposure of the most primitive chronic myeloid leukemia cells to IL-3 and G-CSF through an autocrine mechanism could explain their paradoxically decreased self-renewal in vitro and slow accumulation in vivo, in spite of an increased cycling activity and selective expansion of later compartments.
authors.affiliation: The Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC Canada V5Z 1L3.
authors.forename: X
authors.initials: X
authors.lastname: Jiang
authors.forename: A
authors.initials: A
authors.lastname: Lopez
authors.forename: T
authors.initials: T
authors.lastname: Holyoake
authors.forename: A
authors.initials: A
authors.lastname: Eaves
authors.forename: C
authors.initials: C
authors.lastname: Eaves
mesh_terms: D001483:Base Sequence; D002455:Cell Division; D017931:DNA Primers; D016179:Granulocyte Colony-Stimulating Factor / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology*; D006801:Humans; D007377:Interleukin-3 / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000378:metabolism* / Q000473:pathology; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured
chemical_list: D017931:DNA Primers; D007377:Interleukin-3; D012333:RNA, Messenger; D016179:Granulocyte Colony-Stimulating Factor